Emerging Strategies in Cancer Metabolism

Role of Gut Microbiota, Reactive Oxygen Species, and Short Chain Fatty Acids
Erscheinungsjahr 2025
ISBN: 978-0-443-33459-7
Verlag: Elsevier Science

Buch, Englisch, 320 Seiten, Format (B × H): 191 mm x 235 mm

Emerging Strategies in Cancer Metabolism: Role of Gut Microbiota, Reactive Oxygen Species, and Short Chain Fatty Acids offers a revolutionary investigation of the complicated relationships between cancer metabolism and three crucial factors: the gut microbiota, reactive oxygen species (ROS), and the dysregulation of the short chain fatty acid (SCF) complex. This book adopts a thorough and interdisciplinary approach to untangle the intricate interactions between these components, providing fresh perspectives that fundamentally alters the understanding of cancer biology and therapy. In 14 chapters.

Emerging Strategies in Cancer Metabolism: Role of Gut Microbiota, Reactive Oxygen Species, and Short Chain Fatty Acids provides a thorough investigation of the metabolic changes that occur inside cancer cells, illuminating how these changes promote tumour survival and progression, from introduction to future aspects. Researchers in cancer research, and gut microbiology will find this an essential reference.

Autoren/Hrsg.

Mishra, Neeraj

Rath, Goutam

Anitha, Kuttiappan

Fachgebiete

• Naturwissenschaften Biowissenschaften Biowissenschaften

Inhaltsverzeichnis

1. Introduction to Gut Microbiota in Cancer Metabolism
2. Cancer Metabolic Rewiring of Reactive Oxygen Species
3. Emerging strategies in Cancer metabolism: Role of Gut microbiota, reactive oxygen species, and short chain fatty acids
4. Exploring the Link Between Gut Microbiome and Cancer: Metabolic Implications and Therapeutic Avenue
5. Oxidative Stress and Cancer Metabolism: From Pathogenesis to Therapeutic Opportunities
6. Targeting ROS Signaling Pathways for Cancer Metabolic Reprogramming
7. SCF Complex: Master Regulator of Metabolic Adaptations in Cancer Cells
8. Manipulating gut microbial metabolites for cancer therapy: A Metabolism-centric approach
9. Metabolic Crossroads: Integrating ROS, SCF and Gut Microbiota in Cancer
10. Therapeutic Advances: Modulating Gut Microbiota, ROS, and SCF Pathways in Cancer Treatment
11. Precision Medicine in Cancer Metabolism: Personalized Approaches Exploiting Metabolic Vulnerabilities
12. Novel Biomarkers and Therapeutic Targets: Harnessing Metabolic Insights for Improved Cancer Management
13. Future aspects: Novel Strategies in Cancer Metabolism Research and Clinical Interventions
14. Novel approach in Bridging the Gap between Cancer Biology and Metabolism
15. Implementing Gut Microbiota, ROS, and SCF Modulation in Cancer Care: Research into Practice

Über Autor(innen)

Rath, Goutam
Prof. Goutam Rath is currently serving as Professor in the Department of Pharmaceutics, School of Pharmaceutical Sciences, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar, India. A leading researcher in nanotechnology-based platform technologies for site-specific drug and bioactive delivery, Prof. Rath has earned global recognition for his scientific contributions. He has been listed among the world's top 2% scientists by Stanford University (USA) for four consecutive years (2019-2024). In 2018, he was named one of the Top 10 Scientists of India by Career 360 and was awarded for best GMP practices by the USFDA.

Prof. Rath has successfully led numerous national research projects with cumulative funding exceeding ?22.2 crores from prestigious agencies like NITI Aayog, DBT, DST, AICTE, UGC, and ICMR. He has authored over 250 peer-reviewed publications with a cumulative impact factor of approximately 1080, an h-index of 59, and over 10,800 citations. Additionally, he has contributed to four textbooks, 20 book chapters, and over 60 scientific presentations. His innovative work is protected by 21 patents, six of which have been commercially transferred, generating revenues of ?37 lakhs. He currently supervises 85 M.Pharm and 10 Ph.D. scholars, and serves on multiple national expert panels in biotechnology and nanomedicine.